Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study

$Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study$

Journal article

Peer reviewed

Ola Landgren, Katja Weisel, Laura Rosinol, Cyrille Touzeau, Mehmet Turgut, Roman Hajek, Peter Mollee, Jin Seok Kim, Natalie Shu, Xuguang Hu, …

British journal of haematology

2022-05-24

PMID: 35608261

Metrics

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study
Creators: Ola Landgren - Sylvester Comprehensive Cancer Center
Katja Weisel - Department of Oncology, Hematology and BMT University Medical Center of Hamburg‐Eppendorf Hamburg Germany
Laura Rosinol - Hospital Clínic, IDIBAPS Barcelona Spain
Cyrille Touzeau - Centre Hospitalier Universitaire de Nantes
Mehmet Turgut - Ondokuz Mayıs University
Roman Hajek - University Hospital Ostrava
Peter Mollee - University of Queensland
Jin Seok Kim - Yonsei University
Natalie Shu - Parexel Chengdu China
Xuguang Hu - Amgen
Chuang Li - Amgen Inc. Thousand Oaks California USA
Saad Z. Usmani - Memorial Sloan Kettering Cancer Center
Carl Ola Landgren - Miller School of Medicine
Publication Details: British journal of haematology
Academic Unit: UMMG Department of Medicine; Miller School of Medicine
Language: English
Resource Type: Journal article
PMID: 35608261
Record Identifier: 991031723263602976